1 Mar 2023Open access
Acinetobacter Baumannii: An Emerging Threat to Public Health – A Review of LiteraturePublisher siteZenodo (CERN European Organization for Nuclear Research), Antibiotic Resistance in Bacteria
Active, last published 2026
In antibiotic resistance in bacteria
Okesola Abiola
Olukemi
Scholar“Research focused on Antibiotic Resistance in Bacteria and adjacent fields.”
Claim Your Profile0
H-index
0
Citations
Okesola has not officially claimed their profile. If you are Okesola, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
kesola Abiola Olukemi is a researcher working on Antibiotic Resistance in Bacteria. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Okesola's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Antibiotic Resistance in Bacteria×3
04 · Where I am
Affiliations
Affiliation on published researchUniversity College Hospital, Ibadan, NigeriaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works1 Mar 2023Open access
Acinetobacter Baumannii: An Emerging Threat to Public Health – A Review of LiteraturePublisher siteZenodo (CERN European Organization for Nuclear Research), Antibiotic Resistance in Bacteria
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Okesola?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you